The intrauterine contraceptive device: An often-forgotten and maligned method of contraception

被引:15
作者
Dardano, KL [1 ]
Burkman, RT [1 ]
机构
[1] Baystate Med Ctr, Dept Obstet & Gynecol, Springfield, MA 01199 USA
关键词
candidates for use; intrauterine contraceptive device; levonorgestrel-releasing intrauterine contraceptive device; mechanism of action; pelvic inflammatory disease;
D O I
10.1016/S0002-9378(99)70426-6
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Although 90% of women at risk for unintended pregnancy in the United States use contraception, <1% of these women use the intrauterine contraceptive device. The mechanism of action of intrauterine contraceptive devices has been controversial, but several studies suggest that interference with sperm migration or function and with fertilization may be the most likely mechanisms. More important, there is lack of compelling evidence that the intrauterine contraceptive device acts as an abortifacient. The risk for pelvic inflammatory disease among users now appears to be extremely low, primarily as a result of better selection of candidates. A levonorgestrel-releasing intrauterine contraceptive device may offer some new therapeutic approaches for the treatment of certain gynecologic disorders. Although women who are not at risk for pelvic inflammatory disease or sexually transmitted diseases are appropriate candidates for the intrauterine contraceptive device, it appears that use can be expanded to selected nulliparous women and women with certain medical conditions.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 25 条
[1]  
Abma J C, 1997, Vital Health Stat 23, P1
[2]  
ALVAREZ F, 1988, FERTIL STERIL, V49, P768
[3]  
ANDERSSON K, 1992, OBSTET GYNECOL, V79, P963
[4]  
Burkman R T, 1996, Obstet Gynecol Surv, V51, pS35, DOI 10.1097/00006254-199612000-00013
[5]  
Chi I C, 1994, Obstet Gynecol Surv, V49, P722, DOI 10.1097/00006254-199410000-00028
[6]   The Levonorgestrel-releasing intrauterine device: A wider role than contraception [J].
Coleman, M ;
McCowan, L ;
Farquhar, C .
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1997, 37 (02) :195-201
[7]   Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding [J].
Crosignani, PG ;
Vercellini, P ;
Mosconi, P ;
Oldani, S ;
Cortesi, I ;
DeGiorgi, O .
OBSTETRICS AND GYNECOLOGY, 1997, 90 (02) :257-263
[8]   Intrauterine contraception in nulligravid vs parous women [J].
Duenas, JL ;
Albert, A ;
Carrasco, F .
CONTRACEPTION, 1996, 53 (01) :23-24
[9]   INTERACTIONS BETWEEN INTRAUTERINE CONTRACEPTIVE DEVICE USE AND BREAST-FEEDING STATUS AT TIME OF INTRAUTERINE CONTRACEPTIVE DEVICE INSERTION - ANALYSIS OF TCU-380A ACCEPTORS IN DEVELOPING-COUNTRIES [J].
FARR, G ;
RIVERA, R .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 167 (01) :144-151
[10]   Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device [J].
Fedele, L ;
Bianchi, S ;
Raffaelli, R ;
Portuese, A ;
Dorta, M .
FERTILITY AND STERILITY, 1997, 68 (03) :426-429